Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435429
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-05-24
Brief Title:
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab Each in Combination With Physicians Choice Chemotherapy for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Sponsor:
Jazz Pharmaceuticals
Organization:
Jazz Pharmaceuticals